
Every shift, I watch nurses and physicians click through dozens of alerts they barely read. Override. Override. Override. We've trained an entire generation of clinicians to ignore the systems designed to keep patients safe.
This isn't a character flaw. It's the predictable result of systems that cry wolf hundreds of times a day.
Studies consistently show that clinicians override between 49% and 96% of clinical decision support (CDS) alerts, depending on the institution and alert type. In my own hospital, when we audited our medication alerts last year, we found that providers were overriding 91% of drug-drug interaction warnings.
That number sounds alarming until you look at what was actually being flagged. The vast majority of those alerts were low-severity interactions that any competent clinician would already know about — things like "aspirin interacts with ibuprofen." Of course it does. The physician prescribed both intentionally.
Meanwhile, the handful of genuinely dangerous interactions — the ones that could kill someone — get lost in the noise.
The root cause is almost always the same: alerts are configured by vendors or committees far removed from the clinical workflow. They're designed for legal defensibility, not clinical usefulness.
Here's what I see most often:
At my hospital, we spent 18 months rebuilding our CDS approach. The results were dramatic — and the changes were less technical than you'd think.
First, we reduced total alert volume by 60%. We disabled every low-severity interaction alert and replaced them with passive informational displays. The pharmacist still reviews the order — we just stopped interrupting the ordering provider for things that don't need interrupting.
Second, we added context. Our high-severity alerts now incorporate patient-specific data: renal function, current medications, documented allergies with reaction types. Instead of "Drug A interacts with Drug B," the alert says "This dose of gentamicin may exceed safe levels given this patient's current creatinine clearance of 28 mL/min."
Third, we made the alerts actionable. Every alert now includes a specific recommendation: an alternative medication, a dose adjustment, or a monitoring parameter. Clinicians don't just see the problem — they see a path forward.
The result? Override rates for our remaining high-severity alerts dropped from 87% to 34%. More importantly, we caught three potential adverse events in the first quarter that the old system would have buried in noise.
If your CDS override rate is above 70%, your system isn't protecting patients — it's training clinicians to ignore safety nets. The fix isn't more alerts. It's fewer, better ones.
Work with your pharmacists and physicians to audit what's actually firing. Kill the noise. Invest in context. Make every remaining alert worth the interruption.
Maria Santos, PharmD, BCPS
Maria is a clinical pharmacist specializing in medication safety and informatics. She has spent the last eight years building and refining clinical decision support systems that reduce adverse drug events.
Clinical insights delivered to your inbox. No spam.